peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

thymic pentapeptide

Thymopentin

Published evidence · coverage incomplete

Anatomy in the research

Anatomy evidence is still being assembled.

These are anatomical mentions in cited research—not established treatment targets or proof of benefit in people.

This publication has no anatomy passages that meet our source-linking checks yet. Read the available findings ↓

General anatomy view only. No peptide-specific structures are highlighted.

At a glance

What is it—and why does it matter?

An introduction is not yet available. The findings below address specific research questions, not a complete account of this peptide.

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

How does it work?

Target, response, and disposition.

Mechanism

A single-protein binding-affinity assay for human adenosine receptor A1 (ADORA1) reported that CHEMBL156025 did not reach an AC50 at or below 10000.0 nM (AC50 > 10000.0 nM).

Sources[1]chembl-activitiesChEMBL activities for CHEMBL156025Molecule: CHEMBL156025 Target: Adenosine receptor A1 (CHEMBL226) Assay: Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay Assay format: single protein format Standard result: AC50 > 10000.0 nM
Reported result
AC50 > 10000.0 nM
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “Molecule: CHEMBL156025 Target: Adenosine receptor A1 (CHEMBL226) Assay: Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay Assay format: single protein format Standard result: AC50 > 10000.0 nM”

    ChEMBL activities for CHEMBL156025 · Activity 25132922

    chembl-activities:chembl156025:37aef16baf55:37aef16baf55

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, effect, identity, interaction, regulatory, safety
  • 65 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (53), assurance_score_below_0.72 (11), current_regulatory_source_required (6), extraction_ambiguity (68), high_risk_requires_regulatory_or_two_independent_sources (11), no_direct_support (64)
  • A source-backed introductory overview is not yet available.

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. ChEMBL activities for CHEMBL156025 ↗

    chembl-activities · published 2026-08-30 · retrieved 2026-08-30T08:40:08Z

Publication history and provenance

Version 1 · Automated assessment · 2026-08-30T08:40:08Z

f5f2449ec3d52c1afab66f70627a08242e51a318e647fce1c6e69c83bbd696a3